United States

Synonyms: 
USA
the states
the US
Mon
17
Sep

Washington, DC sees mass synthetic marijuana overdose

Even in cannabis-legal Washington, DC, people are still getting severely sick due to synthetic marijuana.

Synthetic marijuana has caused a string of overdoses in the Washington, D.C. area this week, according to a report in the Washington Post. In one 24-hour period from Wednesday through Thursday, emergency medical personnel took dozens of people to local hospitals for treatment. City officials say the victims had been using K2 or Spice before being stricken.

Mon
17
Sep

Police chiefs warn of increased crime if California allows marijuana deliveries statewide

The prospect of vans loaded with pot delivering to homes in quiet Morgan Hill makes Police Chief David Swing uneasy.

Like most cities in the state, the upscale San Jose suburb has banned pot shops. But now, as California considers a proposal to allow marijuana businesses to send home-delivery vans into communities where retail stores are prohibited, Swing and others in law enforcement say they are preparing for the worst.

“This will make it easier and more lucrative to rob a delivery person than a liquor store,” said Swing, who is president of the California Police Chiefs Assn. He notes drivers would be allowed to carry up to $10,000 in cash. “Robberies are the tip of the iceberg. They can lead to other crimes, including aggravated assaults and homicides.”

Mon
17
Sep

Coca-Cola is eyeing the cannabis market; report says in talks with Aurora

The world's largest beverage company says it is interested in developing drinks containing CBD — the non-psychoactive ingredient in marijuana.

The world’s largest beverage company may be the next industry giant to jump into the cannabis drinks business.

Coca-Cola Co. says it’s monitoring the nascent industry and is interested in CBD — the non-psychoactive ingredient in marijuana — for beverages as soda consumption slows. The Atlanta-based soft drinks maker is in talks with Canadian marijuana producer Aurora Cannabis Inc. to develop the drinks, according to a report from BNN Bloomberg Television.

Mon
17
Sep

Black market marijuana is a big problem, and this new survey proves it

California's cannabis market is leading by example. However, it's not a good example.

The marijuana industry is just over a month away from making history. Following the passage of the Cannabis Act by Parliament on June 19, our neighbor to the north, Canada, is set to become the first industrialized nation to legalize recreational marijuana on Oct. 17. When fully legal, adult-use weed is expected to add billions in annual revenue to the industry.

Mon
17
Sep

Three out of four Michigan communities have opted out of medical program

A recent survey found that three out of four communities in Michigan do not want cannabis businesses in their area.

The survey was conducted by the University of Michigan’s Ford School of Public Policy. Township officials were polled about whether or not they’ve opted in or out of Michigan’s medical cannabis program. The survey found that 75 percent of officials had opted out of the program.

The survey was conducted online for the majority of communities and some by mail. There was a 70 percent response rate according to Tom Ivacko, the associate director of the Center for Local, State, and Urban Policy at the Ford School of Public Policy.

Mon
17
Sep

Marijuana legalization in New York State is inevitable

The question “Should NY legalize marijuana sales to persons 21 years of age or older?” has already been decided. The public is in favor — 63 percent of us say yes. Those who agree represent all political parties, genders, races and ethnicities.

New York state has invested time and resources to study the health, social and economic impacts of legalization in states where marijuana is legal. Economists have run the numbers estimating sales and tax revenue and jobs creation potential for New York state. Conclusions overwhelmingly support legalization in New York state.

Mon
17
Sep

3 Top marijuana stocks Wall Street expects to drop at least 25%

The green rush may soon have investors seeing red.

The big day is rapidly approaching. In just over a month, on Oct. 17, recreational marijuana will go on sale in licensed dispensaries throughout Canada. When fully legal, the sale of adult-use weed is expected to usher in high demand and big dollar figures for the industry.

In anticipation of this legalization -- and the big profits that are projected to follow -- marijuana stock investors and Wall Street have pushed the valuations of many pot stocks into nosebleed territory. Some of these marijuana stocks are still valued modestly below Wall Street's consensus price target per share.

Mon
17
Sep

Marijuana use is suddenly "booming" with this group of people

This is what you call "turning over a new leaf".

The green rush is officially on. In 32 days, Canada will lift the curtain and allow recreational marijuana to be legally sold in licensed dispensaries. Although Uruguay became the first country in the world to legalize adult-use pot, Canada is set to make history by becoming the first industrialized nation to do so. And with this legalization comes the expectation of billions of dollars in annual sales flooding into the industry.

Mon
17
Sep

Massachusetts credit union to provide banking services for cannabis companies

GFA Federal Credit Union will begin working with MA weed businesses on October 1.

Massachusetts’ retail cannabis market is perhaps a week or two away. For Massachusetts’ cannabis consumers and business owners, the official start of retail sales has been a long time coming. For regulators and law enforcement, however, several major concerns remain unsettled.

Mon
17
Sep

The federal government must stop stifling medical marijuana research

In June, for the first time, The Food and Drug Administration  approved a plant-derived medicine from marijuana. The prescription drug, known as Epidiolex, contains a proprietary formulation of cannabis’ organic compounds — primarily cannabidiol (CBD) —for the treatment of severe seizure disorders.

The British pharmaceutical company — the manufacturer of the drug — a has long been licensed by the U.K. government to privately grow strains of cannabis for the purpose of drug development.

Pages

Subscribe to RSS - United States